Talukdar, D.; Jain, V.; Balaramnavar, V.; Srivastava, S.P.; Sivanandy, P.; Gupta, M.M. Potential Drugs for COVID -19 Treatment Management With Their Contraindications and Drug- Drug Interaction. Preprints2021, 2021050690. https://doi.org/10.20944/preprints202105.0690.v1
APA Style
Talukdar, D., Jain, V., Balaramnavar, V., Srivastava, S.P., Sivanandy, P., & Gupta, M.M. (2021). Potential Drugs for COVID -19 Treatment Management With Their Contraindications and Drug- Drug Interaction. Preprints. https://doi.org/10.20944/preprints202105.0690.v1
Chicago/Turabian Style
Talukdar, D., Palanisamy Sivanandy and Madan Mohan Gupta. 2021 "Potential Drugs for COVID -19 Treatment Management With Their Contraindications and Drug- Drug Interaction" Preprints. https://doi.org/10.20944/preprints202105.0690.v1
Abstract
Novel Coronavirus (2019-nCOV) causes inflammatory response with worsening symptoms. Classification of potential anti-viral and anti-inflammatory drugs in managing the symptoms of the COVID-19 and reducing morbidity is important. The objective of this study is to identify a group of drugs, best suited for COVID-19 treatment based on recent developments in clinical trials, FDA drug evaluation, directions and developments and from drug therapies globally. Online literature search was done on Medline, PubMed and google scholar databases for studies on various treatments and drug therapies for COVID-19 and relevant studies were identified and the identified drugs are described in detail as per their Pharmacological, pharmaceutical properties of the drugs, mechanism of action, current COVID-19 drug therapy, contraindications and drug-drug interactions Certain drugs can inhibit action against viral infection and protect lungs from severe inflammatory response. This article summarizes several drugs like Hydroxychloroquine, Chloroquine, Remdesivir, Favipiravir, Lopinavir, Ritonavir, Dexamethasone, Ivermectin, Baricitinib, Casirivimab / imdevimab, Bamlanivimab along with auxiliary treatment like convalescent plasma transfusion. Remdesivir is first drug approved by FDA. Hydroxychloroquine, dexamethasone and remdesivir are showing results against COVID-19 but it is important to test the efficacy and safety of such drugs though some drugs have shown remarkable results.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
,
